Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: A pilot study

Psychoneuroendocrinology

Volumn 22, Issue 1, 1997, Pages 25-38

  Sundström, Inger ^c   Ashbrook, Donald ^a   Bäckström, Torbjörn ^b  

^a Department of Pharmacokinetics and Drug Metabolism   (United States)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

GABA(A) receptor; premenstrual syndrome (PMS); saccadic eye velocity; sedation

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; DYSPHORIA; FEMALE; HUMAN; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; SEDATION; SELF REPORT;

ADULT; AFFECT; ANTI-ANXIETY AGENTS; AROUSAL; DIAZEPAM; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; NEURAL INHIBITION; PAIN MEASUREMENT; PILOT PROJECTS; PREMENSTRUAL SYNDROME; REACTION TIME; RECEPTORS, GABA-A; SACCADES; SYNAPTIC TRANSMISSION;

EID: 0030889591     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(96)00035-2     Document Type: Article

References (42)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn, revised. US Department of Health and Human Services, Washington, DC.
2. Ball DM, Glue P, Wilson S, Nutt DJ (1991) Pharmacology of saccadic eye movements in man: 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. Psychopharmacology 105:361-367.
3. Becker W (1989) Metrics. In: Wurtz RH, Goldberg ME (Eds) The Neurobiology of Saccadic Eye Movements. Elsevier Science Publishers, Amsterdam, pp 13-67.
4. Bergenius J (1984) Caloric and Oculomotor Tests in Neuroaudiological Diagnosis. Diss Dept of Audology, Karolinska Hospital, Stockholm.
5. Bäckström T (1992) Neuroendocrinology of premenstrual syndrome. Clin Obstet Gynecol 35:612-628.
6. Bäckström T, Sanders D, Leask R, Davidson D, Warner P, Bancroft J (1983) Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med 45:503-507.
7. A receptor complex. J Pharmacol Exp Ther 265:1374-1379.
8. Freeman EW, Rickels K, Sondheimer SJ, Polansky M (1995) A double-blind trial of oral progesterone, alprazolam and placebo in treatment of severe premenstrual syndrome. JAMA 274:51-57.
9. Gentles W, Thomas EL (1971) Effect of benzodiazepines upon saccadic eye movements in man. Clin Pharmacol Ther 12:563-576.
10. Glue P, Bailey J, Wilson S, Hudson A, Nutt DJ (1992) Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements. Life Sci 50:25-30.
11. Halbreich U (1990) Gonadal hormones and antihormones, serotonin and mood. Psychopharmacol Bull 26:291-295.
12. Hammarbäck S, Ekholm UB, Backstrom T (1991) Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinol (Copenh) 125:132-137.
13. Hammarbäck S, Bäckström T (1988) Induced anovulation as treatment of premenstrual tension syndrome. Acta Obstet Gynecol Scand 67:159-166.
14. Hammarbäck S, Bäckström T, MacGibbon-Taylor B (1988) Diagnosis of premenstrual tension syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis. J Psychosom Obstet Gynaecol 10:25-42.
15. Hammarbäck S, Damber JE, Bäckström T (1988) Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J Clin Endocrinol Metab 68:125-130.
16. Harrison WM, Endicott J, Rabkin JG, Nee JC, Sandberg D (1987) Treatment of premenstrual dysphoria with alprazolam and placebo. Psychopharmacol Bull 23:150-153.
17. Harrison WM, Sandberg D, Gorman JM, Fyer M, Nee J, Uy J, Endicott J (1989) Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Res 27:183-192.
18. Hikosaka O, Wurtz RH (1989) Modification of saccadic eye movements by GABA-related substances: I. Effect of muscimol and bicuculline in the monkey superior colliculus. J Neurophysiol 53:266-291.
19. Hikosaka O, Wurtz RH (1989) Modification of saccadic eye movements by GABA-related substances: II-effects of muscimol and bicuculline in the monkey substantia nigra pars reticulata. J Neurophysiol 53:292-308.
20. Hommer DW, Matsuo V, Wolkowitz O, Chrousos G, Greenblatt DJ, Weingarter H, Paul SM (1986) Benzodiazepine sensitivity in normal human subjects. Arch Gen Psychiatry 43:542-551.
21. Hopfenbeck JR, Cowley DS, Radant A, Greenblatt DJ, Roy-Burne PP (1995) Effects of diphenhydramine on human eye movements. Psychopharmacology 118:280-286.
22. Johnson MR, Lydiard RB, Ballenger JC (1995) Panic disorder. Pathophysiology and drug treatment. Drugs 49:328-344.
23. Kaspi SP, Otto MW, Pollack MH, Eppinger S, Rosenbaum JF (1994) Premenstrual exacerbation of symptoms in women with panic disorder. J Anx Disorders 8:131-138.
24. Landgren S, Aasly J, Bäckström T, Dubrovsky B, Danielsson E (1987) The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiol Scand 131:33-42.
25. Liebowitz MR, Fyer AJ, Gorman JM, Dillon D, Appleby IL, Levy G, Anderson S, Levitt M, Palij M, Davies SO, Klein DF (1984) Lactate provocation of panic attacks. Arch Gen Psychiat 41:764-770.
26. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004-1007.
27. McAuley JW, Reynolds IJ, Kroboth FJ, Smith RB, Kroboth PD (1995) Orally administered progesterone enhances sensitivity to triazolam in postmenopausal women. J Clin Psychopharmacol 15:3-11.
28. McCormack HM, Home DJ, Sheather S (1988) Clinical application of visual analogue scales: a critical review. Psychol Med 18:1007-1019.
29. McLeod DR, Hoehn-Saric R, Foster GV, Hipsley PA (1993) The influence of premenstrual syndrome on ratings of anxiety in women with generalized anxiety disorder. Acta Psychiatr Scand 88:248-251.
30. Norberg L, Wahlström G, Bäckström T (1987) The anaesthetic potency of 3α-hydroxy-5α-pregnan-20-one and 3α-hydroxy-5β-pregnan-20-one determined with an intravenous EEG-threshold method in male rats. Pharmacol Toxicol 61:42-47.
31. Okada Y (1992) The distribution and function of gamma-aminobutyric acid (GABA) in the superior colliculus. In: Mize RR, Marc RE, Silito AM (Eds) Progress in Brain Research, Elsevier Science Publishers, Amsterdam, Oxford, pp 249-262.
32. Parry BL, Gerner RH, Wilkins JN, Halaris AE, Carlson HE, Hershman JM, Linnoila M, Merrill J, Gold PW, Gracely R (1991) CSF and endocrine studies of premenstrual syndrome. Neuropsychopharmacology 5:127-137.
33. Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311-2322.
34. Reame NE, Marshall JC, Kelch RP (1992) Pulsatile LH secretion in women with premenstrual syndrome (PMS): Evidence for normal neuroregulation of the menstrual cycle. Psychoneuroendocrinology 17:205-213.
35. Redei E, Freeman EW (1995) Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology 20:259-267.
36. Roy-Burne PP, Cowley DS, Greenblatt DJ, Shader RI, Hommer D (1990) Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry 47:534-538.
37. Sandberg D, Endicott J, Harrison W, Nee J, Gorman J (1996) Sodium lactate infusion in late luteal phase dysphoric disorder. Psychiat Res 46:79-88.
38. Schmidt PJ, Purdy RH, Moore PH, Paul SM, Rubinow DR (1994) Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79:1256-1260.
39. Schumacher M, Corini H, McEwen B (1989) Regulation of high-affinity GABAA receptors in specific brain regions by ovarian hormones. Neuroendocrinology 50:315-320.
40. Smith S, Rinehart JS, Ruddock VE, Schiff I (1987) Treatment of premenstrual syndrome with alprazolam: Results of a double-blind, placebo-controlled, randomized crossover clinical trial. Obstet Gynecol 70:37-43.
41. Wang M, Seippel L, Purdy R, Bäckström T (1996) Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregneolone sulfate, 5α-pregnan-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. J Clin Endocrinol Metab 81:1076-1082.
42. Wieland S, Lan NC, Mirasedeghi S, Gee KW (1991) Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res 565:263-268.